Imaina Widagdo

ORCID: 0000-0002-0669-0183
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Frailty in Older Adults
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Practices and Patient Outcomes
  • Nutrition and Health in Aging
  • Intensive Care Unit Cognitive Disorders
  • Geriatric Care and Nursing Homes
  • Diet and metabolism studies
  • Medication Adherence and Compliance
  • Pharmaceutical studies and practices
  • Digital Imaging in Medicine
  • Healthcare cost, quality, practices
  • Insurance, Mortality, Demography, Risk Management
  • Statistical Methods in Epidemiology
  • Meta-analysis and systematic reviews

University of South Australia
2011-2025

Background: there are several different frailty measures available for identifying the frail elderly. However, their predictive performance in an Australian population has not been examined. Objective: to examine of four internationally validated older population. Methods: a retrospective study Longitudinal Study Ageing (ALSA) with 2,087 participants. Frailty was measured at baseline using phenotype (FP), simplified (SFP), index (FI) and prognostic score (PFS). Odds ratios (OR) were...

10.1093/ageing/afv144 article EN Age and Ageing 2015-10-26

To test the association between use of medicines with anticholinergic or sedative properties and physical function, cognitive appetite frailty.

10.1136/bmjopen-2019-029221 article EN cc-by-nc BMJ Open 2019-09-01

Identifying patient health conditions in observational studies is essential for accurately measuring healthcare practices and planning effective policy interventions. This analysis evaluates the validity of Rx-Risk Index, a tool that uses medication dispensing data to identify comorbidities measure overall health. We examined an updated version reflecting changes treatment practices, assess its as identifying specific aid risk adjustment studies. conducted validation study using two...

10.2147/cia.s494145 article EN cc-by-nc Clinical Interventions in Aging 2025-03-01

Aim To determine the prevalence of frailty in a cohort older A ustralians. Methods Frailty status 2087 participants ustralian L ongitudinal S tudy geing was assessed based on questionnaire responses at baseline interview. and were using four measures: two unidimensional measures (the Phenotype Simplified Phenotype) multidimensional (Frailty Index Prognostic Score). Agreement between determined. Results The identified more people as frail (17.5 49.4%) than did (2 8.8%). There little agreement...

10.1111/ajag.12184 article EN Australasian Journal on Ageing 2015-06-02

Aged care residents are vulnerable to the harmful effects of medicines; however, data on prevalence and preventability adverse medicine events in aged scarce. To determine Australian residents. A secondary analysis from Reducing Medicine-Induced Deterioration Adverse Reactions (ReMInDAR) trial was conducted. Potential were identified independently screened by two research pharmacists produce a short-list potential events. An expert clinical panel reviewed each likelihood that event related...

10.1007/s40264-023-01299-z article EN cc-by-nc Drug Safety 2023-04-19

Residents of aged-care facilities have high rates adverse drug events. This study aimed to identify risk factors for events in residents. was a secondary using data from multicentre randomised controlled trial. Data 224 residents whom there 6 months baseline information were analysed. We assessed the and falls (post hoc) subsequent months. Adverse identified via key word search resident care record adjudicated by multidisciplinary panel modified version Naranjo criteria. Covariates through...

10.1007/s40266-022-00983-6 article EN cc-by-nc Drugs & Aging 2022-11-23

ABSTRACT Background The Beers criteria are used to identify potentially inappropriate medications (PIMs) in the elderly. Few studies have examined elderly hospitalised patients Australia. Aim To prevalence of PIM use admitted an Australian hospital using 2003 criteria. Method A prospective cross‐sectional study 100 inpatients was undertaken and compare on admission discharge. Logistic regression analysis risk factors for use. Results 42% had at least one compared 39% most common PIMs were...

10.1002/j.2055-2335.2011.tb00678.x article EN Journal of Pharmacy Practice and Research 2011-06-01

10.1080/08164622.2023.2288178 article EN Clinical and Experimental Optometry 2024-01-04

Abstract Background Frailty and medicine‐related problems are common among the elderly have been associated with an increased risk of adverse outcomes. However, there has limited research on association between frailty medicines use. Aim To determine distribution older people who used to examine difference in scores over time continuation or discontinuation specific medicines. Methods The study population was from Australian Longitudinal Study Ageing (ALSA). data analysis were collected 1992...

10.1002/jppr.1407 article EN publisher-specific-oa Journal of Pharmacy Practice and Research 2018-09-23

Abstract Introduction Frailty is increasingly recognised as a dynamic syndrome, with multiple causes, dimensions and consequences. There little understanding of how those frailty assessment metrics interact over time. The aim this study was to describe the longitudinal correlation between five metrics, namely multimorbidity, muscular strength, mood alterations, cognitive capacity, functional capacity in cohort aged care (nursing home) residents. Methods 248 residents Index at baseline <...

10.1007/s40520-023-02491-y article EN cc-by Aging Clinical and Experimental Research 2023-07-14

Aim: To examine the incidence and nature of medicine-related problems over time experienced by nursing home residents. Method: We analyzed records collected in Reducing Medicine-Induced Deterioration Adverse Events (ReMInDAR) trial. The trial pharmacists provided services to reduce medicine-induced deterioration adverse reactions for residents every 8-weeks a year. identified were documented reports subsequently classified independently research using D.O.C.U.M.E.N.T system. number type at...

10.3389/fphar.2022.978871 article EN cc-by Frontiers in Pharmacology 2022-08-29
Coming Soon ...